IPP Bureau
China aims to lead next bio revolution in advanced biologics, says GlobalData
By IPP Bureau - December 15, 2022
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Takeda launches CINRYZE in India for hereditary angioedema patients
By IPP Bureau - December 15, 2022
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
ELIX Polymers and Ayudame3D to produce prostheses using recovered ABS
By IPP Bureau - December 15, 2022
Ayúdame3D has become a leading social entity in social technology.
Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
By IPP Bureau - December 15, 2022
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Torrent enters into co-marketing partnership with Boehringer Ingelheim India
By IPP Bureau - December 15, 2022
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
Briefs: Jubilant Pharmova and Apollo Hospitals Enterprise
By IPP Bureau - December 15, 2022
The company will submit an action plan on the observations and will engage with US FDA for next steps.
Kerala Ayurveda receives US patent for its herbal formulation
By IPP Bureau - December 15, 2022
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
LG Chem inks deal with Innovent Biologics for gout treatment candidate
By IPP Bureau - December 15, 2022
LG Chem will receive totaling up to $95.5 million for the China rights
Seeq achieves AWS Life Sciences Competency status
By IPP Bureau - December 15, 2022
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
De Nora and Aclarity sign agreement to deploy PFAS destroying technology
By IPP Bureau - December 15, 2022
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Hovione and GEA collaborate to advance continuous tableting
By IPP Bureau - December 15, 2022
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
By IPP Bureau - December 14, 2022
The investment will enable the company to enter European markets as well as enhance margins in current markets
AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
By IPP Bureau - December 14, 2022
Sanjeev is currently the Country President for AstraZeneca Malaysia
JB Pharma to buy Glenmark's ‘Razel’ for Rs. 314 crore in India and Nepal
By IPP Bureau - December 14, 2022
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
BSV receives exclusive marketing and distribution right for NexoBrid in India
By IPP Bureau - December 14, 2022
To focus on providing safer burn treatments for women and armed forces
